Skip to main content
. 2009 Jun;11(6):1415–1452. doi: 10.1089/ars.2008.2280

FIG. 6.

FIG. 6.

Schematic view of PPARγ activation in VSMCs. In VSMCs, TZDs attenuate growth factor–induced (e.g., AngII) cell migration, proliferation, and fibrosis in either a PPARγ-dependent or -independent manner by interfering with growth factor–stimulated signaling pathways. PPARγ activation exerts antiinflammatory roles by inhibiting the NF-κB pathway; PPARγ activation promotes apoptosis via inducing IRF-1 or GADD45 expression.